# SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy

> **NCT04015245** · PHASE4 · COMPLETED · sponsor: **Chimei Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Stronger Neo-Minophagen C

## Key facts

- **NCT ID:** NCT04015245
- **Lead sponsor:** Chimei Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2019-05-09
- **Final completion:** 2019-05-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04015245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04015245, "SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04015245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*